Vimarsana
Biggest News Aggregation in the World

Page 9 - Okapi Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Okapi Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Okapi Partners Today - Breaking & Trending Today

NewGAMe provides update on regulatory filings required to - Vimarsana News

NewGAMe provides update on regulatory filings required to

Geneva, Sept. 18, 2023 (GLOBE NEWSWIRE) -- NewGAMe provides update on regulatory filings required to increase GAM shareholding to 20-30% Geneva, 18...

The Swiss Takeover Board rules on NewGAMe's partial offer - Vimarsana News

The Swiss Takeover Board rules on NewGAMe's partial offer

Geneva, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Swiss Takeover Board rules on NewGAMe's partial offer for GAM shares Geneva, 31 August 2023 – The investor...

Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts - Vimarsana News

Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts

Tekla Healthcare Investors , Tekla Life Sciences Investors , Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund , today announced that their joint first special meetings of...

ISS Continues to Support Need for Board Change at Nano Dimension – But Murchinson Does Not Believe Recommendation Goes Far Enough - Vimarsana News

ISS Continues to Support Need for Board Change at Nano Dimension – But Murchinson Does Not Believe Recommendation Goes Far Enough

ISS Acknowledges Murchinson Has Made a Case for Change at Nano, Highlighting the Market’s Lack of Faith in Company’s Strategy and “Significant Concerns Regarding the Governance Structure and...

Longeveron Rights Offering Declared Effective and Calendar - Vimarsana News

Longeveron Rights Offering Declared Effective and Calendar

MIAMI, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing...